Nanochon, Inc.

SEC filing

Biotechnology · Washington, DC

Form D on EDGAR

Amount raised$3.6Msold at filing

Total offering$4.2M$641K still open

Investors in the raise39count reported to the SEC

FiledFeb 5, 2026first sale Dec 24, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Benjamin HolmesExecutive Officer, Director

Nick PachudaDirector

Kurt JacobusDirector

Robert CreedenDirector

Sean ChurchillDirector

Executive officers, directors and promoters as listed on the Form D.